VIP — Research Overview
VIP (Vasoactive Intestinal Peptide) is a laboratory-supplied synthetic peptide reference compound provided exclusively for controlled non-clinical laboratory and educational research use.
In research environments, VIP may be utilized for analytical characterization, receptor-interaction modeling, and in-vitro assay development within controlled laboratory systems.
VIP is a synthetic peptide sequence corresponding to vasoactive intestinal peptide, a 28–amino acid neuropeptide referenced extensively in peptide chemistry and receptor-modeling literature. It is commonly studied in molecular interaction systems involving peptide–receptor binding dynamics.
This compound is supplied as a reference material for laboratory workflows involving:
- Peptide–receptor interaction modeling
- Sequence characterization studies
- Analytical method development
- Stability and degradation profiling
- Comparative peptide evaluation
All investigations involving this compound are conducted exclusively in controlled, non-clinical laboratory environments. No conclusions regarding biological, physiological, neurological, or therapeutic outcomes are established by its availability as a research material.
Chemical Name
Vasoactive Intestinal Peptide (synthetic reference form)
Chemical Classification
Synthetic neuropeptide
Molecular Formula
C147H237N43O43S
Molecular Weight
3326.86 g/mol
Structural Characteristics
28–amino acid peptide sequence referenced in neuropeptide modeling literature
- Peptide–Receptor Interaction Modeling — Evaluation of binding dynamics within controlled receptor assay systems.
- Stability Profiling — Assessment of peptide integrity and degradation parameters under defined laboratory conditions.
- Comparative Analytical Evaluation — Examination of peptide-related parameters within assay development workflows.
- Molecular Characterization — Structural and sequence-based modeling within peptide chemistry research environments.
- Analytical Reference Applications — Application in assay calibration and validation involving synthetic peptide compounds (non-clinical).
All studies are conducted exclusively in controlled, non-clinical laboratory environments. No claims regarding biological outcomes, physiological effects, neurological effects, or therapeutic applications are stated or implied.
VIP is referenced in peptide chemistry literature as a synthetic neuropeptide studied in receptor-interaction modeling systems. In laboratory research settings, it serves as a reference compound for analytical workflows and structural characterization studies.
This material is not intended to represent or substitute any approved product, treatment, or clinical program.
Any information provided is for scientific and educational context only and should be interpreted strictly within controlled research environments.
Important Research Notice
VIP is supplied strictly for laboratory and educational research use. It is not intended for human or animal use and is not provided for diagnostic, therapeutic, preventative, neurological, or medical applications.
Purchasers are responsible for ensuring proper handling, storage, and use in accordance with applicable laws, regulations, and institutional policies.
Selected Academic References
• Neuropeptide receptor modeling literature
• Synthetic peptide characterization publications
• Analytical assay development references
• Stability and structural profiling studies
(References are provided solely for academic and informational context.)
Research-Use Only (RUO)
All products and information provided on this website are intended solely for laboratory, scientific, and educational research purposes. VIP is not a drug, food, dietary supplement, or medical product. It is not intended for human or animal consumption or use. Products are not intended for injection, ingestion, topical application, or any form of bodily introduction. No content on this website constitutes medical advice, clinical guidance, or endorsement. Any non-research use is strictly prohibited.
